Skip to main content
Home

Main navigation

  • Innovation

        Innovation

      • Overview
      • Capabilities
      • Innovation is
      • Pipeline
      • Drug discovery
      • Clinical studies
      • Publications

      You might be interested in...

      Picture of two UCB scientists reviewing data
      Story
      9 Jan 2025

      UCB and Ailux Biologics Join Forces to Transform Biologics Research

      Page

      Publications - A dedicated space where we share a collection of our scientific peer-reviewed...

      Page

      Pipeline - Check out our clinical development pipeline spanning several therapy areas

  • Solutions

        Solutions

      • Overview
      • Healthcare professionals
      • Diseases
      • Medicines

      You might be interested in...

      Page

      Hidradenitis Suppurativa – Learn more about Hidradenitis Suppurativa an inflammatory skin disease

      Page

      WoCBA - Closing the gaps in research in the care of women of childbearing age with chronic diseases

      Page

      Clinical studies – Click to find out more on our clinical studies

  • About UCB

        About UCB

      • Overview
      • Management
      • Sustainability
      • Our positions
      • Ethics & Business Integrity
      • Collaborate with us

      You might be interested in...

      Page

      Integrated Annual Report 2024 - Click here to access the report

      Page

      UCBCares® - Discover what UCBCares® is about and the services they offer

      Picture of the Arkelia building on the Braine-l'Alleud campus in Belgium
      Story
      10 Feb 2025

      Driving innovation forward: UCB unveils new R&D facility

  • Newsroom

        Newsroom

      • Overview
      • Press releases
      • Our stories
      • Resources
      • Contact details

      You might be interested in...

      Press Release
      27 Feb 2025

      On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

      Press Release
      12 Feb 2025

      BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in...

      Press Release
      31 Jan 2025

      RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two...

  • Investors

        Investors

      • Overview
      • Equity Story
      • Performance
      • Corporate governance
      • Shareholders
      • Download center

      You might be interested in...

      Press Release
      27 Feb 2025

      On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

      Press Release
      5 Nov 2024

      UCB completes sale of established brands and updates 2024 financial guidance

      Page

      Download center – Click here to view a collection of useful documents

  • Careers
  • Go to global site 
Country Navigator

US

US

Listen

You are here

  • Home
  • Patients
  • Parkinson's Well-Being Map
  • US

Choose a Country

  • Global Site – English
  • Australia – English
  • België – Engels
  • Belgique – Anglais
  • Brasil – Português
  • България – Български
  • Canada – English
  • Canada – Français
  • 中国 – 中文
  • Česká Republika – Angličtina
  • Danmark – Engelsk
  • Deutschland – Deutsch
  • France – Français
  • España – Español
  • Ελλάδα – Ελληνικά
  • India – English
  • Ireland – English
  • Italia – Inglese
  • 日本 – 日本語
  • 한국 – 한국어
  • Luxembourg – Anglais
  • Luxemburg – Engels
  • Magyarország – Angol
  • México & Latinoamérica – Español
  • Nederland – Engels
  • New Zealand – English
  • Norge – Engelsk
  • Österreich – Deutsch
  • Polska – Polski
  • Portugal – español y portugués
  • România – Engleză
  • Россия – Русский
  • Slovensko – Anglický
  • Suomi – Englanti
  • Sverige – Engelska
  • Schweiz – Deutsch
  • Suisse – Français
  • Türkiye – Türkçe
  • Україна – Англійська
  • United Kingdom – English
  • U.S.A. – English

© 2007 - 2025 UCB S.A., Belgium. All rights reserved. Last updated on: November, 14, 2024

Social media links

  • linkedin
  • instagram
  • facebook
  • twitter
  • youtube

Footer menu

  • Contact us
  • UCBCares®
  • UCB Worldwide
  • Legal Notice
  • Privacy policies
  • Cookie policies
  • Cookie preferences
  • Payment disclosure
  • Sitemap

© 2007 - 2025 UCB S.A., Belgium. All rights reserved. Last updated on: March, 12, 2025